We recently announced the development of our new INSTI SARS-CoV-2 Antibody Test. Based on the 1-minute INSTI platform, the test will detect antibodies to SARS-CoV-2, the virus that causes COVID-19. We have been supported by the government’s NRC IRAP, which has provided advice and financial resources to Canadian companies for more than 70 years, helping them bring innovative ideas to market. When completed, the test will be a helpful tool for supporting the medical community in monitoring the spread of the virus.
Our scientists are still hard at work developing the test, but our Chief Scientific Officer, Michelle Zaharik took some time out of her busy schedule to speak to journalists about this exciting news: